| Issue Date |
Title |
Author(s) |
| 2015 |
Abiraterone acetate after docetaxel-based chemotherapy failure in Asian patients with metastatic castration-resistant prostate cancer |
Ye, Dingwei;Zou, Qing;Sun, Zhongquan;Sun, Yinghao;Li, Changling;Du, Chuanjun;Chen, Zhiwen;Shan, Yuxi;Huang, Yiran;Jin, Jie;Ye, Zhang Qun;Xie, Liping;Feng, Yi;De Porre, Peter;Liu, Weiping;Ye, Dingwei |
| 2015 |
Abiraterone acetate after docetaxel-based chemotherapy failure in Asian patients with metastatic castration-resistant prostate cancer |
Ye, Dingwei;Zou, Qing;Sun, Zhongquan;Sun, Yinghao;Li, Changling;Du, Chuanjun;Chen, Zhiwen;Shan, Yuxi;Huang, Yiran;Jin, Jie;Ye, Zhang Qun;Xie, Liping;Feng, Yi;De Porre, Peter;Liu, Weiping;Ye, Dingwei |
| 2016 |
Abiraterone acetate for metastatic castration-resistant prostate cancer after docetaxel failure: A randomized, double-blind, placebo-controlled phase 3 bridging study |
Sun, Yinghao;Zou, Qing;Sun, Zhongquan;Li, Changling;Du, Chuanjun;Chen, Zhiwen;Shan, Yuxi;Huang, Yiran;Jin, Jie;Ye, Zhang Qun;Xie, Liping;Lin, Guowen;Feng, Yi;De Porre, Peter;Liu, Weiping;Ye, Dingwei |
| 2015 |
Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0-10.0 ng/ml |
Chen, Rui;Huang, Yiran;Cai, Xiaobing;Xie, Liping;He, Dalin;Zhou, Liqun;Xu, Chuanliang;Gao, Xu;Ren, Shancheng;Wang, Fubo;Ma, Lulin;Wei, Qiang;Yin, Changjun;Tian, Ye;Sun, Zhongquan;Fu, Qiang;Ding, Qiang;Zheng, Junhua;Ye, Zhangqun;Ye, Dingwei;Xu, Danfeng;Hou, Jianquan;Xu, Kexin;Yuan, Jianlin;Gao, Xin;Liu, Chunxiao;Pan, Tiejun;Sun, Yinghao |
| 2019 |
Application of fluorescence in situ hybridization in the detection of bladder transitional-cell carcinoma: A multi-center clinical study based on Chinese population |
Zhou, Liqun;Yang, Kaiwei;Li, Xuesong;Ding, Yi;Mu, Dawei;Li, Hanzhong;Yan, Yong;Li, Jinyi;Wang, Dongwen;Li, Wei;Cong, Yulong;Gao, Jiangping;Ma, Kewei;Xiao, Yajun;Zhang, Sheng;Jiang, Hongyi;Hu, Weilie;Wei, Qiang;Jin, Xunbo;Guan, Zhichen;Liu, Qingyong;Xu, Danfeng;Gao, Xin;Jiang, Yongguang;Gan, Weimin;Sun, Guang;Wang, Qing;Liu, Yanhui;Hou, Jianquan;Xie, Liping;Song, Xishuang;Jin, Fengshuo;Feng, Jiafu;Cai, Ming;Liang, Zhaozhao;Zhang, Jie;Ye, Dingwei;Qi, Lin;Ma, Lulin;Shou, Jianzhong;Dai, Yuping;Shao, Jianyong;Tian, Ye;Hong, Shizhe;Xu, Tao;Kong, Chuize;Kang, Zefeng;Liu, Yuexin;Qu, Xun;Shi, Benkang;Zheng, Shaobin;Lin, Yi;Xia, Shujie;Wei, Dong;Wu, Jianbo;Fu, Weiling;Wang, Zhiping;Liang, Jianbo |
| 2016 |
Development and external multicenter validation of Chinese Prostate Cancer Consortium prostate cancer risk calculator for initial prostate biopsy |
Chen, Rui;Xie, Liping;Xue, Wei;Ye, Zhangqun;Ma, Lulin;Gao, Xu;Ren, Shancheng;Wang, Fubo;Zhao, Lin;Xu, Chuanliang;Sun, Yinghao |
| Aug-2020 |
The efficacy and safety of Geptanolimab (GB226) in patients with relapsed/refractory peripheral T cell lymphoma (PTCL): A multicenter, open-label, single-arm, phase 2 trial |
Shi, Yuankai;Wu, Jianqiu;Wang, Zhen;Zhang, Liling;Wang, Zhao;Zhang, Mingzhi;Cen, Hong;Peng, Zhigang;Li, Yufu;Fan, Lei;Guo, Ye;Ma, Liping;Cui, Jie;Gao, Yuhuan;Yang, Haiyan;Zhang, Hongyu;Wang, Lin;Zhang, Weihua;Zhang, Huilai;Xie, Liping;Jiang, Ming;Zhou, Hui;Shuang, Yuerong;Su, Hang;Ke, Xiaoyan;Jin, Chuan;Du, Xin;Du, Xin;Liu, Li;Xi, Yaming;Ge, Zheng;Feng, Ru;Zhang, Yang;Zhou, Shengyu;Xie, Fan;Gao, Chao |
| 2019 |
Efficacy and safety of ranibizumab 0.5 mg in Chinese patients with visual impairment due to diabetic macular edema: results from the 12-month REFINE study |
Li, Xiaoxin;Dai, Hong;Li, Xiaorong;Han, Mei;Li, Jun;Suhner, Andrea;Lin, Renxin;Wolf, Sebastian;Li, Xiaoxin;Qi, Huijun;Tao, Ye;Li, Yan;Bai, Yujing;Yin, Hong;Liu, Guodong;Han, Li;Qian, Tong;Huang, Lvzhen;Miao, Heng;Zhao, Mingwei;Hou, Jing;Cheng, Yong;Liang, Jianhong;Shi, Xuan;Qu, Jinfeng;Yu, Wenzhen;Tao, Yong;Chen, Yi;Zhang, Feng;Shi, Xuehui;Gao, Liqin;Ding, Ning;Yang, Lihong;Zhao, Shiqiang;Yang, Qiong;Shen, Rong;Xiong, Ying;Dong, Fangtian;Zhang, Xiao;Gong, Di;Qu, Yi;Dai, Fangfang;He, Feng;Han, Xiaoxu;Dai, Rongping;Du, Hong;Yu, Weihong;Li, Donghui;Yang, Zhikun;Ma, Zhizhong;Zhang, Min;Dou, Hongliang;Chen, Xiuhong;Chu, Ying;Ren, Jing;Qian, Fang;Yang, Fan;Zhao, Lin;Ding, Aihua;Guo, Tong;Lu, Xinrong;Liu, Yuling;Wang, Xin;Yang, Liu;Li, Jun;Zhu, Ruilin;Hao, Jianchen;Qiao, Lijun;Guo, Chunying;Zhang, Jing;Nie, Hongping;Gu, Xiaopeng;Du, Lixiao;Zhang, Yadi;Zhang, Wenbo;Zhang, Shijie;Hao, Jianchen;Zhao, Liang;Shi, Jingmei;Wu, Hailong;Dai, Hong;Huang, Jianfeng;Zhao, Jing;Hu, Lei;Yu, Xiaobing;Lu, Yingyi;Peng, Nuan;Gu, Xiaoya;Long, Li;Shi, Zian;Wang, Yanling;Zhao, Lu;Zhang, Xiaolei;Hou, Yanli;Huang, Yinxiang;Li, Mingming;Zhang, Fan;Hong, Hui;Wang, Kang;Tang, Simeng;Liu, Dachuan;Junjie, Bian;lei, Zhang;Dai, Weijia;Huiqing, Yang;Ning, Hao;Wang, Xizhe;Zhao, Liyan;Li, Xiaorong;Wang, Shaorui;Wang, Linni;Han, Jindong;Chen, Lu;Ma, Jinghua;Ma, He;Li, Zhiqing;Wang, Tingting;Yu, Rongguo;Dong, Xiaojun;Li, Ying;Guo, Junlin;Hu, Yahan;Sheng, Xueyong;Li, Shuang;Han, Mei;Cong, Chunxia;Li, Li;Han, Ying;Xu, Yanshan;Ma, Nannan;Xie, Shiyong;Lu, Lin;Hu, Andina;Lian, Ping;Ma, Wei;Su, Guangxing;Yuan, Miner;Lai, Wangying;Li, Xiaofang;Chen, Guangxian;Yu, Xiling;Mai, Guiying;Zhong, Junying;Chen, Xing;Liu, Bingqian;Liu, Yuhong;Zhao, Xiujuan;Mo, Qinmei;Cheng, Jiangmei;Yang, Hui;Yang, Qiufen;Zhong, Xiaojing;Jin, Chenjin;He, Caiqing;Xie, Qiuhua;Huang, Ping;Mai, Xiaoxi;Zhong, Jingxiang;Zhang, Xiaoming;Liu, Xiaoyong;Zhang, Ting;Zhang, Liqiong;Wang, Guifang;He, Xiaojuan;Meng, Jing;Zhang, Rijia;Tian, Yuan;Chen, Weiqi;Chen, Shirong;Huang, Bingrong;Zhang, Guihua;Zhang, Anlin;Liu, Xinyu;Zheng, Kangkeng;Zhou, Lingling;Chen, Haoyu;Peng, Kun;Zhou, Zhaotao;Lin, Dusheng;Huang, Huichun;Lin, Xiaoang;Zhang, Junjun;Zhang, Meixia;Zhu, Helian;Huang, Xi;Xin, Mei;Zeng, Zhibing;Meng, Dan;Wu, Ye;Wu, Qianying;Ma, Lin;Lai, Zhifeng;Gao, Sheng;Wang, Xiaoyue;Ren, Juqin;Qiu, Guoxian;Ye, Jian;Liao, Hongxia;Tang, Ying;Tao, Lusha;Liu, Shaozhang;Yue, Li;Feng, Sijia;Xu, Jie;Dong, Yan;Tan, Nian;Chen, Yanli;Chen, Shaoqiong;Zhao, Peiquan;Wang, Zhaoyang;Dong, Yang;Man, Xiaofei;Ji, Xunda;Tian, Tian;Feng, Huazhang;Li, Xin;Huang, Qiujing;Wang, Shiyuan;Cai, Kebo;Zhang, Qi;Li, Yian;Jin, Haiying;Sun, Xiaodong;Zheng, Kairong;Feng, Jingyang;Ye, Liang;Shih, Alice;Liu, Xiaoxiao;Cai, Zhengyuan;Wu, Ying;Fan, Ying;He, Ping;Xie, Liping;Sun, Jian;Duan, Zhongju;Zhao, Tingting;Wang, Weijun;Cheng, Lu;Yao, Pang;Wu, Zhifeng;Xu, Huiyan;Zhang, Jie;Zhu, Dongyuan;Meng, Xiaomei;Fu, Yuting;Chen, Tiantian;Lu, Shui;Zou, Wenjun;Shen, Ye;Tong, Jianping;Yu, Chengying;Lu, Hong;Wu, Qin;Fan, Wenting;Huang, Baishuang;Wang, Xiaoen;Hong, Nan;Wu, Miaoqin;Li, Xiaoxia;Zheng, Qingqing;Chen, Yurong;Xu, Hong;Liu, Hui;Liu, Zhe;Shen, Ting;Guo, Hong;Zhang, Luyi;Chi, Xinchang;Zhao, Hailan;Yu, Jie;Zhang, Lan;Song, Yanping;Ding, Qin;Qiu, Jinlan;Liu, Yan;Dong, Yangting;Chang, Feng;Chen, Zhongshan;Chen, Yunhui;Yan, Ming;Huang, Zhen;Huang, Zhijian;Ma, Lina;Du, Qian;Zhang, Mingchang;Li, Pengcheng;Yan, Wenhui;Zheng, Hai;Xu, Kangkang;Fang, Jing;Wei, Jingjing;Yang, Junjie;Sheng, Shuangyan;Ao, Qiong;Liu, Xiaoling;Ge, Lina;Zhou, Tingye;Zhu, Qianqian;Lin, Bing;Luo, Yingdong;Huang, Ying;Zeng, Leilei;Zheng, Weiwei;Yan, Miaojun;Sun, Zuhua;Wang, Yusheng;Zhang, Peng;Wang, Haiyan;Zhu, Jinting;Yu, Xiaoni;Li, Manhong;Wang, Qihua;Li, Juan;Bai, Wenle;Hou, Huiyuan;Zhang, Zifeng;He, Jin;Sun, Dongjie;Song, Xiaojin;Tang, Luosheng;Zhao, Fei;Zhang, Kun;Ouyang, Pingbo;Zeng, Jun;Liu, Jia;Wei, Wei;Tian, Jiao;Xu, Haifeng;Li, Jun;Xu, Jing;Wang, Min;Shi, Depeng;Wu, Peipei;Sun, Dawei;Shi, Liping;Jiang, Bo;Cheng, Fang;Jia, Danhua;Zhang, Zhongyu;Zhou, Xuemei;Song, Wulian;Shen, Ling;Fan, Pan;Yi, Jinglin;Yang, Haijun;Zuo, Yanping;Zeng, Jiao;Liu, Yan;Du, Hongyan;Yu, Li;Liu, Xian;Wan, Shenghui;Zhu, Si;Li, Qiulin;Dong, Wenjia |
| 2016 |
Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 Activation |
Xie, Liping;Gu, Yue;Wen, Mingliang;Zhao, Shuang;Wang, Wan;Ma, Yan;Meng, Guoliang;Han, Yi;Wang, Yuhui;Liu, George;Moore, Philip K.;Wang, Xin;Wang, Hong;Zhang, Zhiren;Yu, Ying;Ferro, Albert;Huang, Zhengrong;Ji, Yong |
| 2016 |
Influence of a single-nucleotide polymorphism of the DNA mismatch repair-related gene exonuclease-1 (rs9350) with prostate cancer risk among Chinese people |
Zhang, Yiming;Li, Pengju;Xu, Abai;Chen, Jie;Mao, Chao;Sakai, Akiko;Xie, Liping;Wang, Lei;Na, Yanqun;Kaku, Haruki;Xu, Peng;Jin, Zhong;Li, Xiezhao;Guo, Kai;Shen, Haiyan;Zheng, Shaobo;Kumon, Hiromi;Liu, Chunxiao;Huang, Peng |
| 2014 |
A multicenter, noncontrolled clinical study of sorafenib adjuvant therapy in advanced renal cell carcinoma |
Ye, Dingwei;He, Zhisong;Sun, Yinghao;Kong, Chuize;Xie, Liping;Wei, Qiang;Ye, Zhangqun;Li, Min;Shen, Zhoujun;Li, Hanzhong;Sun, Guang;Ma, Jianhui |
| 2017 |
Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts |
Chen, Rui;Sjoberg, Daniel D.;Huang, Yiran;Xie, Liping;Zhou, Liqun;He, Dalin;Vickers, Andrew J.;Sun, Yinghao |
| 22-Jul-2021 |
S-nitrosylation-mediated coupling of G-protein alpha-2 with CXCR5 induces Hippo/YAP-dependent diabetes-accelerated atherosclerosis |
Chao, Meng-Lin;Luo, Shanshan;Zhang, Chao;Zhou, Xuechun;Zhou, Miao;Wang, Junyan;Kong, Chuiyu;Chen, Jiyu;Lin, Zhe;Tang, Xin;Sun, Shixiu;Tang, Xinlong;Chen, Hongshan;Wang, Hong;Wang, Dongjin;Sun, Jin-Peng;Han, Yi;Xie, Liping;Ji, Yong |
| 2011 |
Single Nucleotide Polymorphism WRN Leu1074Phe Is Associated with Prostate Cancer Susceptibility in Chinese Subjects |
Wang, Lei;Kaku, Haruki;Huang, Peng;Xu, Kexin;Yang, Kai;Zhang, Jiheng;Li, Ming;Xie, Liping;Wang, Xiaofeng;Sakai, Akiko;Watanabe, Masami;Nasu, Yasutomo;Shimizu, Kenji;Kumon, Hiromi;Na, Yanqun |
| Jun-2020 |
The status and characteristics of urinary stone composition in China |
Ye, Zhangqun;Zeng, Guohua;Yang, Huan;Li, Jianxin;Tang, Kun;Wang, Guomin;Wang, Shusheng;Yu, Yonggang;Wang, Yujie;Zhang, Tao;Long, Yongfu;Li, Weibin;Wang, Changmin;Wang, Wei;Gao, Sihe;Shan, Yuxi;Huang, Xiaobo;Bai, Zhiming;Lin, Xiaohan;Cheng, Yue;Wang, Qinzhang;Xu, Zhuoqun;Xie, Liping;Yuan, Jianlin;Ren, Shengqiang;Fan, Yuhui;Pan, Tiejun;Wang, Jing;Li, Xun;Chen, Xuehua;Gu, Xiaojian;Sun, Zhaolin;Xiao, Kefeng;Jia, Jianye;Zhang, Qinghua;Wang, Gongxian;Sun, Ting;Li, Xuedong;Xu, Changbao;Xu, Chuangliang;Shi, Guowei;He, Jiayang;Song, Leming;Sun, Guang;Wang, Dongwen;Liu, Yili;Wang, Chunxi;Han, Yi;Liang, Peiyu;Wang, Zhiping;He, Wei;Chen, Zhiqiang;Xing, Jinchun;Xu, Hua |
| 2019 |
y Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial |
Ye, Zhangqun;Huang, Jian;Zhou, Liqun;Chen, Shan;Wang, Zengjun;Ma, Lulin;Wang, Dongfang;Wang, Gongxian;Wang, Shusheng;Liang, Chaozhao;Qiu, Shaopeng;Gu, Xiaojian;Liu, Jianhe;Weng, Zhiliang;Wu, Changli;Wei, Qiang;Xie, Liping;Wu, Weizhen;Cheng, Yue;Hu, Jingqian;Wang, Zhixian;Zeng, Xiaoyong |
